McKesson Corporation (MCK:NYSE)
McKesson Corporation (MCK) is a healthcare services provider which operates globally. It was founded in 1833 and is headquartered in Irving, Texas. The company operates in four segments: U.S. Pharmaceutical, International, Medical Surgical solutions and Prescription Technology Solutions (RxTS).
The Pharmaceutical segment provides over the counter (OTC), specialty, branded, generic drugs and other healthcare related products. It also provides services such as practice management, technology, clinical support, business solutions & consulting and other services. This segment accounts for the majority of MCK’s revenue (80%).
The Medical-Surgical solutions segment supplies medical-surgical equipment, logistics and other services.
Prescription Technology Solutions (RxTS) segment works with other biopharma and life sciences partners to address medical challenges for patients. It also provides services which connect pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions.
The international segment provides distribution and services to wholesale, institutional and retail clients across 13 European countries and Canada.